Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells

Food and Chemical Toxicology

Volumn 48, Issue 6, 2010, Pages 1619-1626

  Popovich, David G ^a   Li, Lu ^a   Zhang, Wei ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

3T3 L1; Adipogenesis; Bitter melon; Momordica charantia; PPAR ; Saponins

Indexed keywords

ADIPONECTIN; BETA ACTIN; LACTATE DEHYDROGENASE; LIPID; MOMORDICA CHARANTIA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; TRITERPENOID; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID STORAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROADIPOCYTE; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; L-LACTATE DEHYDROGENASE; MASS SPECTROMETRY; MICE; MOMORDICA CHARANTIA; PLANT EXTRACTS; PPAR GAMMA; TRITERPENES;

CUCUMIS; MOMORDICA CHARANTIA;

EID: 77952882291     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.03.035     Document Type: Article

References (37)

1. Ahmed I., Adeghate E., Sharma A.K., Pallot D.J., Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res. Clin. Pract. 1998, 40(3):145-151.
2. Arner P. The adipocyte in insulin resistance. Key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 2003, 14(3):137-145.
3. Arner P. Insulin resistance in type 2 diabetes - role of the adipokines. Curr. Mol. Med. 2005, 5(3):333-339.
4. Basch E., Gabardi S., Ulbricht C. Bitter melon (Momordica charantia): a review of efficacy and safety. Am. J. Health Syst. Pharm. 2003, 60(4):356-359.
5. Camp H.S., Ren D., Leff T. Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol. Med. 2002, 8(9):442-447.
6. Cummings E., Hundal H.S., Wackerhage H., Hope M., Belle M., Adeghate E., Singh J. Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Mol. Cell. Biochem. 2004, 261(1-2):99-104.
7. Daval M., Foufelle F., Ferre P. Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. 2006, 574(Pt 1):55-62.
8. Furnsinn C., Waldhausl W. Thiazolidinediones: metabolic actions in vitro. Diabetologia 2002, 45(9):1211-1223.
9. Gil-Campos M., Canete R.R., Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin. Nutr. 2004, 23(5):963-974.
10. Green H., Meuth M. An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3(2):127-133.
11. Gregoire F.M. Adipocyte differentiation: from fibroblast to endocrine cell. Exp. Biol. Med. 2001, 226(11):997-1002.
12. Grossman S.L., Lessem J. Mechanisms and clinical effects of thiazolidinediones. Expert Opin. Invest. Drugs 1997, 6(8):1025-1040.
13. Grover J.K., Yadav S.P. Pharmacological actions and potential uses of Momordica charantia: a review. J. Ethnopharmacol. 2004, 93(1):123-132.
14. Hammarstedt A., Andersson C.X., Rotter S.V., Smith U. The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73(1):65-75.
15. Hwang J.T., Kim S.H., Lee M.S., Kim S.H., Yang H.J., Kim M.J., Kim H.S., Ha J., Kim M.S., Kwon D.Y. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochem. Biophys. Res. Commun. 2007, 364(4):1002-1008.
16. Hwang J.T., Lee M.S., Kim H.J., Sung M.J., Kim H.Y., Kim M.S., Kwon D.Y. Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways. Phytother. Res. 2009, 23(2):262-266.
17. Leatherdale B.A., Panesar R.K., Singh G., Atkins T.W., Bailey C.J., Bignell A.H. Improvement in glucose tolerance due to Momordica charantia (karela). Br. Med. J. (Clin. Res. Ed) 1981, 282(6279):1823-1824.
18. Murakami T., Emoto A., Matsuda H., Yoshikawa M. Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chem. Pharm. Bull. (Tokyo) 2001, 49(1):54-63.
19. Nerurkar P.V., Lee Y.K., Motosue M., Adeli K., Nerurkar V.R. Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. Br. J. Nutr. 2008, 100(4):751-759.
20. Oishi Y., Sakamoto T., Udagawa H., Taniguchi H., Kobayashi-Hattori K., Ozawa Y., Takita T. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci. Biotechnol. Biochem. 2007, 71(3):735-740.
21. Popov A.M. Comparative study of cytotoxic and hemolytic effects of triterpenoids isolated from Ginseng and Sea cucumber. Izv. Akad. Nauk Ser. Biol. 2002, 2:155-164.
22. Popovich D.G., Kitts D.D. Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line. Arch. Biochem. Biophys. 2002, 406(1):1-8.
23. Popovich D.G., Kitts D.D. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2. Can. J. Physiol. Pharmacol. 2004, 82(3):183-190.
24. Popovich, D.G., Yeo, S.Y., Zhang, W., 2009. Ginseng (Panax quinquefolius) and Licorice (Glycyrrhiza uralensis) root extract combinations increase hepatocarcinoma cell (Hep-G2) viability. Evid. Based. Complement Alternat. Med., doi:10.1093/ecam/nep074.
25. Roffey B.W., Atwal A.S., Johns T., Kubow S. Water extracts from Momordica charantia increase glucose uptake and adiponectin secretion in 3T3-L1 adipose cells. J. Ethnopharmacol. 2007, 112(1):77-84.
26. Rudich A., Tirosh A., Potashnik R., Hemi R., Kanety H., Bashan N. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 1998, 47(10):1562-1569.
27. Sarkar S., Pranava M., Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res. 1996, 33(1):1-4.
28. Sathishsekar D., Subramanian S. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats. Biol. Pharm. Bull. 2005, 28(6):978-983.
29. Senanayake G.V., Maruyama M., Shibuya K., Sakono M., Fukuda N., Morishita T., Yukizaki C., Kawano M., Ohta H. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats. J. Ethnopharmacol. 2004, 91(2-3):257-262.
30. Sridhar M.G., Vinayagamoorthi R., Suyambunathan V.A., Bobby Z., Selvaraj N. Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br. J. Nutr. 2008, 99(4):806-812.
31. Trayhurn P., Beattie J.H. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 2001, 60(3):329-339.
32. Vuksan V., Sievenpiper J.L., Koo V.Y., Francis T., Beljan-Zdravkovic U., Xu Z., Vidgen E. American ginseng (Panax quinquefolius L.) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch. Intern. Med. 2000, 160(7):1009-1013.
33. Welihinda J., Karunanayake E.H., Sheriff M.H., Jayasinghe K.S. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 1986, 17(3):277-282.
34. Wink M. Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Curr. Drug Metab. 2008, 9(10):996-1009.
35. Zhang W., Popovich D.G. Effect of soyasapogenol A and soyasapogenol B concentrated extracts on HEP-G2 cell proliferation and apoptosis. J Agric. Food Chem. 2008, 56(8):2603-2608.
36. Zhang W., Popovich D.G. Chemical and biological characterization of oleanane triterpenoids from soy. Molecules 2009, 14(8):2959-2975.
37. Zhang W., Yeo M.C., Tang F.Y., Popovich D.G. Bioactive responses of Hep-G2 cells to soyasaponin extracts differs with respect to extraction conditions. Food Chem. Toxicol. 2009, 47(9):2202-2208.